posted on 2017-05-09, 04:25authored byNATALIE JEAN KINGSTON
This research investigated the use of hepatitis B surface antigen (HBsAg) virus-like
particles (VLPs) as vaccine platforms for the delivery of foreign antigens in immune
systems with prior HBsAg exposure.